Outcomes of Patients With Autosomal Dominant Polycystic Kidney Disease Prescribed SGLT2 Inhibitors in British Columbia: A Single-Arm Retrospective Cohort Study. Here, SLC5A2 is linked to autosomal dominant polycystic kidney disease.